Anchor Investment Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Anchor Investment Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-73	Closed	-$4.76K	–	817
2019 Q1	$4.76K	Hold	73	–	–	﹤0.01%	690
2018 Q4	$4.55K	Hold	73	–	–	﹤0.01%	703
2018 Q3	$5.37K	Hold	73	–	–	﹤0.01%	719
2018 Q2	$4.91K	Hold	73	–	–	﹤0.01%	737
2018 Q1	$4.55K	Hold	73	–	–	﹤0.01%	716
2017 Q4	$4.68K	Buy	+73	New	+$4.68K	﹤0.01%	717

Other funds holding PJP

BCI

Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Anchor Investment Management's PJP Position: Q2 2019 in Review

Anchor Investment Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2019, closing a stake of 73 shares — an estimated $4.76K sold.

Anchor Investment Management first reported a position in PJP in Q4 2017 and held it in 6 quarters. The position peaked at $5.37K in Q3 2018. 83 funds tracked by Wall St. Rank hold PJP as of Q2 2019.

Anchor Investment Management reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2019 after selling out during the quarter.
Anchor Investment Management sold 73 Invesco Pharmaceuticals ETF shares in Q2 2019, an estimated $4.76K.
Anchor Investment Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2017 and held it in 6 quarters.
Anchor Investment Management's Invesco Pharmaceuticals ETF position peaked at $5.37K in Q3 2018.
83 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2019.

Based on Anchor Investment Management's 13F filing for Q2 2019, filed 3 Jan 2024.